European Medicines Agency
Last updated on 2013-11-20T01:23+0300.
About this
image
License:
UNKNOWN
| Key Titles and Phrases | Count | Lang | Last Seen |
|---|
| Names | Lang | Count |
|---|---|---|
| European Medicines Agency | EN | 17.30% |
| European medicines agency | DE | 5.87% |
| European medicines agency | PT | 5.87% |
| European medicines agency | FR | 5.87% |
| European medicines agency | NL | 5.87% |
| European medicines agency | EN | 5.87% |
| Agence européenne des médicaments | FR | 5.05% |
| European Medicines Agency | DE | 4.94% |
| European Medicines Agency | PT | 4.94% |
| European Medicines Agency | FR | 4.84% |
| European Medicines Agency | NL | 4.74% |
| European Medicines Agency | RO | 4.74% |
| European Medicines Agency | BS | 4.74% |
| European Medicines Agency | EU | 4.74% |
| Agence européenne des médicaments | EN | 3.09% |
| Agence Européenne des Médicaments | FR | 1.75% |
| Agencia Europea de Medicamentos | ES | 1.65% |
| Agence Européenne des Médicaments | EN | 1.65% |
| agence européenne des médicaments | FR | 1.65% |
| agence européenne des médicaments | EN | 1.65% |
| European Medicine Agency | EN | 1.24% |
| Europäische Arzneimittelagentur | DE | 1.13% |
| Europees Geneesmiddelenbureau | NL | 0.51% |
| Europejska Agencja Leków | PL | 0.21% |
| Europäische Arzneimittelagentur | EN | 0.10% |
| Европейское Агентство Оценки Медицины | RU | 0.00% |
| Type | Entity Name | Count |
|---|---|---|
 | Medicines Agency | 13.06% |
 | Commission | 5.87% |
| Inc | 5.36% |
| Drug Administration | 5.26% |
| European Union | 4.55% |
| Risk Factors | 2.83% |
| European Commission | 2.73% |
| Annual Meeting | 2.63% |
| American Society | 2.63% |
| World Health Organization | 1.72% |
| Pfizer Inc | 1.52% |
| Clinical Development | 1.42% |
| Research Development | 1.42% |
| Janssen Cilag | 1.21% |
| Health Service Executive | 1.21% |
| Cancer Society | 1.11% |
| Pharmaceuticals Inc | 1.11% |
| Association | 1.01% |
| American Cancer Society | 1.01% |
| CP | 0.91% |
| Novartis | 0.91% |
| Philip Watt | 0.81% |
| Bristol Myers Squibb | 0.81% |
| EC | 0.71% |
| Reuters Group | 0.71% |
| New England Journal of Medicine | 0.71% |
| GlaxoSmithKline | 0.71% |
| United Nations | 0.61% |
| The Lancet | 0.61% |
| Simon Harris | 0.61% |
| Type | Entity Name | Score |
|---|---|---|
| Medicines Agency | 0.1286 |
| Drug Administration | 0.0416 |
| Risk Factors | 0.0247 |
| Annual Meeting | 0.0242 |
| American Society | 0.0235 |
| Philip Watt | 0.0229 |
| Toine Manders | 0.0227 |
| Gordon McVie | 0.0169 |
| Bjørn Hansen | 0.0147 |
| Pfizer Inc | 0.0145 |
| Clinical Development | 0.0142 |
| Research Development | 0.0137 |
| Janssen Cilag | 0.0123 |
| David Pitts | 0.0122 |
| Health Service Executive | 0.0118 |
| Inc | 0.0112 |
| Cancer Society | 0.0106 |
| Pharmaceuticals Inc | 0.0099 |
| American Cancer Society | 0.0096 |
| CP | 0.0086 |
| Novartis | 0.0083 |
| Bristol Myers Squibb | 0.0076 |
| EC | 0.0071 |
| Christi Shaw | 0.0071 |
| GlaxoSmithKline | 0.0068 |
| New England Journal of Medicine | 0.0067 |
| European Commission | 0.0063 |
| Simon Harris | 0.0061 |
| The Lancet | 0.0059 |
| Helen Torley | 0.0053 |
Show/hide duplicate news articles.
Show/hide duplicate news articles.
Tools
Sunday, December 15, 2019
3:03:00 AM EAT
Languages 
Select your languages
Explore Relations
Please send any comments or suggestions to 